Equatorial Guinea vs Senegal: HIV/AIDS deaths averted by antiretroviral therapy
HIV/AIDS deaths averted by antiretroviral therapy over time
- Equatorial Guinea
- Senegal
How they compare
Equatorial Guinea currently reports 2,224 deaths against 2,002 deaths in Senegal, a difference of 222 deaths.
That makes Equatorial Guinea's figure about 1.1 times Senegal's.
The two have swapped places 5 times across 33 shared years of data; in 1990 it was Senegal ahead.
Equatorial Guinea ranks 54th and Senegal ranks 57th of 157 countries.
Across the 4 decades both report, Equatorial Guinea averaged higher in 1 and Senegal in 2.
Head to head by decade
| Decade | Equatorial Guinea | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 135.6 deaths | 481.41 deaths | 345.81 deaths | Senegal |
| 2010s | 1,274 deaths | 1,757 deaths | 482.88 deaths | Senegal |
| 2020s | 2,173 deaths | 1,987 deaths | 185.8 deaths | Equatorial Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Equatorial Guinea or Senegal?
- Equatorial Guinea, at 2,224 deaths against 2,002 deaths in Senegal as of 2022.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Equatorial Guinea and Senegal?
- 222 deaths, with Equatorial Guinea ahead.
- How many years of comparable data are there for Equatorial Guinea and Senegal?
- 33 years are reported by both, from 1990 to 2022.
- How do Equatorial Guinea and Senegal rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Equatorial Guinea ranks 54th and Senegal ranks 57th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.